Troy Edward Wilson has an estimated net worth of $31.6 Million. This is based on reported shares across multiple companies, which include Kura Oncology, Inc., Zosano Pharma Corp, Avidity Biosciences, Inc., PUMA BIOTECHNOLOGY, INC., and Atrium Therapeutics, Inc..

2020 was Troy Edward Wilson's most active year for acquiring shares with 18 total transactions. Troy Edward Wilson's most active month to acquire stocks was the month of May. 2020 was Troy Edward Wilson's most active year for disposing of shares, totalling 37 transactions. Troy Edward Wilson's most active month to dispose stocks was the month of July. 2024 saw Troy Edward Wilson paying a total of $550,594.05 for 691,541 shares, this is the most they've acquired in one year. In 2020 Troy Edward Wilson cashed out on 1,501,494 shares for a total of $16,988,228.85, their largest year based on trade value.